← All trials
NCT06898814
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 9, 2025
- Primary completion
- Jun 1, 2027
- Completion date
- Sep 14, 2027
- First posted
- Mar 27, 2025
- Last posted
- Aug 27, 2025
- Enrollment
- 210
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of CopenhagenLead sponsor
- University of CopenhagenOfficial
- University of CopenhagenCollaborator
- University of CopenhagenCollaborator
- Svendborg HospitalCollaborator
- University of CopenhagenSponsor investigator
- University of Southern DenmarkCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.